Recap: Invitae Q2 Earnings

Shares of Invitae NVTA fell 9.39% in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share fell 48.08% over the past year to ($0.77), which missed the estimate of ($0.70).

Revenue of $46,191,000 declined by 13.62% from the same period last year, which beat the estimate of $39,620,000.

Guidance

Invitae hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Conference Call Details

Date: Aug 04, 2020

Time: 04:30 PM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fir.invitae.com%2Fnews-and-events%2Fevents%2Fdefault.aspx&eventid=2395781&sessionid=1&key=BDF50309DC65A5CD73D8F0B44E49504C&regTag=&sourcepage=register

Technicals

52-week high: $35.33

52-week low: $7.42

Price action over last quarter: Up 93.14%

Company Overview

Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.